In addition, our bioluminescent imaging demonstrated that Nestin knockdown rendered NSCLC cells more sensitive to 17-AAG in a subcutaneous tumor model in vivo, whereas the cytotoxicity of 17-AAG was attenuated in NSCLC tumors overexpressing Nestin (Fig. 8e, f). Here, NES is linked to non-small cell lung carcinoma.